Aktuellt
SENASTE
OssDsign, the medtech company which creates patient-specific cranial implants and synthetic bone graft used in i.e., spinal fusion surgery, is looking to us like a good recovery story after the pandemic. We argue that “return to normal” elective care levels will be the main driver. We highlight the large hospital backlogs, which will be the main driver throughout 2022 and 2023. We forecast a return to sequential growth with revenue growth of 26% y-o-y.
LÄS MER
